Skip to main content

New This Week

Measure Summaries

Society of Thoracic Surgeons Get Alerts

Withdrawn Measure Summaries

The measure summary listed below has been withdrawn from the NQMC Web site because it is no longer in current use, and therefore, does not meet the NQMC Inclusion Criteria. Please see the Measure Summaries Archive for a complete list of measures that have been withdrawn from the NQMC Web site.

Oncology Nursing Society Get Alerts

  • NQMC:009617

Breast cancer: percentage of cycles where patients who are prescribed a potentially myelosuppressive chemotherapy regimen receive a prescription for colony-stimulating factor (CSF) to begin within 24 to 72 hours after chemotherapy administration.

  • NQMC:009623

Breast cancer: percentage of patients who had documentation of follow-up care (recommendations) during the 12-month period after completing the final component of the treatment plan for breast imaging, coordination of care, LVEF assessment, and pelvic exam.

  • NQMC:009624

Breast cancer: percentage of patients who had moderate or greater fatigue at baseline (end of treatment) and had improvement in fatigue from baseline to most recent visit in chart during the 12-month period after completing the final component of the treatment plan.

  • NQMC:009625

Breast cancer: percentage of patients who had moderate or greater psychosocial distress at baseline (end of treatment) and had improvement in psychosocial distress from baseline to most recent visit in chart during the 12-month period after completing the final component of the treatment plan.

  • NQMC:009622

Breast cancer: percentage of patients who made progress toward goals by the end of the 12-month period after completing the final component of the treatment plan.

  • NQMC:009613

Breast cancer: percentage of patients who received a recommendation for an exercise program prior to the first chemotherapy treatment.

  • NQMC:009615

Breast cancer: percentage of patients with a documented assessment for chemotherapy-induced nausea and vomiting prior to the second round of moderately or highly emetogenic chemotherapy treatment.

  • NQMC:009610

Breast cancer: percentage of patients with a documented assessment for distress, fatigue and sleep-wake disturbance after breast cancer diagnosis and prior to the first chemotherapy treatment.

  • NQMC:009612

Breast cancer: percentage of patients with a documented intervention for psychosocial distress score of 4 or greater on the NCCN Distress Thermometer or moderate or greater psychosocial distress via any other validated tool or narrative note at any visit.

  • NQMC:009614

Breast cancer: percentage of patients with a documented intervention for sleep-wake disturbance of 4 or greater on the PROMIS scale, or moderate or greater sleep-wake disturbance determined via any tool or narrative note at any visit.

  • NQMC:009611

Breast cancer: percentage of patients with a documented re-assessment for distress, fatigue and sleep-wake disturbance at least one time each chemotherapy cycle.

  • NQMC:009618

Breast cancer: percentage of patients with at least one documented assessment during the 12-month period after completing the final component of the treatment plan for each of the following: fatigue, pain, psychosocial distress, sleep; assessment for bone health risk, lymphedema, menopausal symptoms, or neuropathy as applicable to the patient based on the types of treatments received.

  • NQMC:009619

Breast cancer: percentage of patients with at least one documented intervention to manage significant levels of symptoms for bone health risk, fatigue, lymphedema, menopausal symptoms, neuropathy, pain, psychosocial distress and sleep.

  • NQMC:009621

Breast cancer: percentage of patients with at least one goal for the post-treatment period documented based on a patient identified topic that was established collaboratively between the patient and the healthcare team, shortly before the final treatment date or in the survivorship time period.

  • NQMC:009616

Breast cancer: percentage of patients with documented education on neutropenia precautions prior to or at the time of the first chemotherapy administration.

  • NQMC:009620

Breast cancer: percentage of patients with documented education or reinforcement of prior education on community resources, diet, exercise, late effects, and signs and symptoms of recurrence; documented education on lymphedema as applicable to the patient based on the treatments received.

About NQMC Measure Summaries

NQMC provides structured summaries containing information about measures and their development.

Submit Measures

Learn how to submit your evidence-based measures.